Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 87 points (0.5%) at 16,606 as of Thursday, May 8, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,938 issues advancing vs. 1,065 declining with 159 unchanged. The Health Services industry currently sits up 0.3% versus the S&P 500, which is up 0.5%. On the negative front, top decliners within the industry include Humana ( HUM), down 1.7%, WellPoint ( WLP), down 0.6% and Fresenius Medical Care AG & Co. KGaA ( FMS), down 0.6%. Top gainers within the industry include Novadaq Technologies ( NVDQ), up 12.0%, CR Bard ( BCR), up 1.8%, Intuitive Surgical ( ISRG), up 1.7%, Becton Dickinson ( BDX), up 1.6% and Boston Scientific ( BSX), up 1.2%. TheStreet would like to highlight 3 stocks pushing the industry lower today: 3. Kindred Healthcare ( KND) is one of the companies pushing the Health Services industry lower today. As of noon trading, Kindred Healthcare is down $1.41 (-5.9%) to $22.40 on heavy volume. Thus far, 436,044 shares of Kindred Healthcare exchanged hands as compared to its average daily volume of 538,100 shares. The stock has ranged in price between $21.87-$23.13 after having opened the day at $22.87 as compared to the previous trading day's close of $23.81. Kindred Healthcare, Inc. provides healthcare services in the United States. It operates in four divisions: Hospital, Nursing Center, Rehabilitation, and Care Management. Kindred Healthcare has a market cap of $1.3 billion and is part of the health care sector. Shares are up 20.6% year-to-date as of the close of trading on Wednesday. Currently there are 3 analysts that rate Kindred Healthcare a buy, 1 analyst rates it a sell, and 4 rate it a hold. TheStreet Ratings rates Kindred Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, poor profit margins and weak operating cash flow. Get the full Kindred Healthcare Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.